Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Idera Pharmaceuticals stock
Learn how to easily invest in Idera Pharmaceuticals stock.
Idera Pharmaceuticals Inc is a biotechnology business based in the US. Idera Pharmaceuticals shares (IDRA) are listed on the NASDAQ and all prices are listed in US Dollars. Idera Pharmaceuticals employs 32 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Idera Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IDRA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Idera Pharmaceuticals stock price (NASDAQ: IDRA)Use our graph to track the performance of IDRA stocks over time.
Idera Pharmaceuticals shares at a glance
|Latest market close||$0.59|
|52-week range||$0.51 - $6.14|
|50-day moving average||$0.69|
|200-day moving average||$0.99|
|Wall St. target price||$1.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.10|
Buy Idera Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Idera Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Idera Pharmaceuticals price performance over time
|1 week (2022-01-18)||-11.52%|
|1 month (2021-12-23)||-2.70%|
|3 months (2021-10-25)||-32.22%|
|6 months (2021-07-23)||-43.81%|
|1 year (2021-01-25)||-90.13%|
|2 years (2020-01-24)||-68.45%|
|3 years (2019-01-25)||2.72|
|5 years (2017-01-25)||1.47|
Idera Pharmaceuticals financials
|Gross profit TTM||$-16,707,000|
|Return on assets TTM||-52.91%|
|Return on equity TTM||88.57%|
|Market capitalisation||$34.5 million|
TTM: trailing 12 months
Idera Pharmaceuticals share dividends
We're not expecting Idera Pharmaceuticals to pay a dividend over the next 12 months.
Have Idera Pharmaceuticals's shares ever split?
Idera Pharmaceuticals's shares were split on a 1:8 basis on 29 July 2018. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Idera Pharmaceuticals shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Idera Pharmaceuticals shares which in turn could have impacted Idera Pharmaceuticals's share price.
Idera Pharmaceuticals share price volatility
Over the last 12 months, Idera Pharmaceuticals's shares have ranged in value from as little as $0.51 up to $6.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Idera Pharmaceuticals's is 1.5879. This would suggest that Idera Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Idera Pharmaceuticals overview
Idera Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Idera Pharmaceuticals in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questionsWhat percentage of Idera Pharmaceuticals is owned by insiders or institutions?
Currently 21.819% of Idera Pharmaceuticals shares are held by insiders and 11.79% by institutions. How many people work for Idera Pharmaceuticals?
Latest data suggests 32 work at Idera Pharmaceuticals. When does the fiscal year end for Idera Pharmaceuticals?
Idera Pharmaceuticals's fiscal year ends in December. Where is Idera Pharmaceuticals based?
Idera Pharmaceuticals's address is: 505 Eagleview Boulevard, Exton, PA, United States, 19341 What is Idera Pharmaceuticals's ISIN number?
Idera Pharmaceuticals's international securities identification number is: US45168K4058 What is Idera Pharmaceuticals's CUSIP number?
Idera Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 44860M108
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Ask an Expert